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he aim of this work was to characterize six hydroxyapatites in granular form for applications in medicine and dentistry as
bone graft and to compare with manufacturers´ specification. These samples were produced by four different manufacturers,
and all of them are easily available in the Brazilian market. Physicochemical characterization was carried out by using electron
microscopy (SEM), X-ray diffraction (XRD), infrared spectroscopy (FTIR) and surface area (BET) measurements. The results
show that just one hydroxyapatite sample exhibited characterisitics in perfect agreement with the manufacturers’ specifications.
The studied parameters, namely crystallinity, surface area and composition may be used to estimate hydroxyapatite’s
biodegradability and as a criterion for quality control.
Uniterms: Hydroxyapatite; Calcium phosphate; Bone graft; Physicochemical characterization.
    objetivo desse trabalho foi caracterizar seis hidroxiapatitas granulares para aplicação em área médico-odontológica como
material de enxerto. Estes materiais foram produzidos por quatro diferentes fabricantes e são todos facilmente disponíveis no
mercado brasileiro. A caracterização físico-química foi realizada por meio de microscopia eletrônica de varredura, difração de
raios-X, espectroscopia de infravermelho e área superficial específica (BET). Os resultados mostraram que apenas um dos
produtos teve a caracterização perfeitamente de acordo com a especificação do fabricante. Os parâmetros de cristalinidade,
área superficial e composição podem ser usados para estimar a biodegradabilidade da hidroxiapatita e como critério de controle
de qualidade desses materiais.
Unitermos: Hidroxiapatita; Fosfato de cálcio; Enxerto ósseo; Caracterização físico-química.
INTRODUCTION
The use of biomaterials for hard tissue replacement has
grown as a consequence of the increase in reconstructive
surgeries that require, in most cases, adjuvant grafting8.
Several applications of bone graft materials in medicine and
dentistry, such as  bone repair, augmentation and substitution
can be highlighted11.  According to data from the Brazilian
Ministry of Health, the number of surgical procedures using
hydroxyapatites as bone graft has more than doubled
between 2002 and 2003.  Bone graft may be obtained from
different origins: autogenous (from the same individual,
highly osteogenic), allogeneic graft (banked freeze-dried
bones of human cadavers), xenogenous (usually bovine
bone-derived) or synthetic calcium phosphate materials11,13.
Autografts are considered the “gold standard” for bone repair
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and substitutions12, but they could only be taken in limited
amounts. On the other hand, allografts and xenografts are
sometimes avoided due to the potential transmission of
infectious diseases15.
Calcium phosphate (Ca-P) materials can be found in nature
(coralline hydroxyapatite) or synthesized by precipitation
methods using chemical reagents1. Hydroxyapatite,
Ca10(PO4)6(OH)2 - HA, is the most well known and studied
calcium phosphate. In medical and dental fields, the term
“hydroxyapatite” is sometimes used to describe any calcium
phosphate material. Synthetic Ca-P grafts may be the chosen
material, especially when large defects need to be filled. It is
generally accepted that these bioceramics are only
osteoconductive (have the ability to support tissue ingrowth
and bone formation) and non-osteoinductive, which means
ability to form bone when implanted in non-osseous sites3.
In several cases, synthetic materials can be mixed with
autogenous bone in order to increase the osteogenic behavior.
The bone graft material may be either resorbable or non-
resorbable, with this classification being related to the extent
of dissolution of Ca-P materials. The factors affecting the
dissolution properties were similar to those affecting
biodegradation or bioresorption9,11. According to Ducheyne
and Qiu8, the larger the solubility rate of the ceramic, the more
pronounced the enhancement effect of bone tissue growth.
Among several factors, chemical composition, particles size
and cristallinity are likely to affect the ceramics solubility,
which may be adjusted for the desired purpose. Different
applications require materials with different resorption rates,
which can be regulated by the mixture of several calcium
phosphate phases.
The extent of calcium phosphate ceramics (CPC)
dissolution in acidic buffer increases from crystalline
hydroxyapatite to amorphous apatite, with tricalcium
phosphate exhibiting medium solubility12. Magnesium or
carbonate substitutions were shown to cause reduction in
crystal size and an increase of dissolution of synthetic
apatites12. For the same composition, the resorption increases
with the decrease in crystallinity and with the increase in
surface area5. Crystallinity is highly dependent on sintering
temperature: the higher the sintering temperature, the more
perfect the crystal and thus the lower the degradation rate.
Resorbable calcium phosphate materials are usually unsintered
Ca-P materials.
Changes in composition and cristallinity of calcium
phosphate-based materials from one manufacturer to another
or even from different batches of the same manufacturer were
observed. These variations can be a consequence of lack of
control in the manufacturing process and directly affect the
clinical result, becoming a limiting factor for the use of this
material11.
The purpose of this study was to determine the
physicochemical properties of six commercial hydroxyapatite
granules available in the Brazilian market, comparing the
results obtained with information from manufacturers’
specifications.
MATERIALS AND METHODS
A total of six hydroxyapatite samples in granular form
were used in this study: two were imported (HA-4 and HA-6),
although they are easily available in the Brazilian market, and
four of them were made in Brazil. Concerning the degradation
rate, four samples were indicated by the producer as
resorbable materials (from HA-3 to HA-6) and the other two –
HA-1 and HA-2 - as non-resorbable. According to the
products’ specifications, the hydroxyapatite granules were
either of bovine origin (named “natural”) – HA-5 and HA-6)
or by using synthetic routes (HA-1, HA-2, HA-3 and HA-4).
Information following packing was quite variable. The
manufacturers’ names were not disclosed to protect their
identities.
The granules were bought from or, alternatively, donated
by manufacturers and characterized without further treatment.
The following characteristics were determined: granules
morphology, size range and surface area. The presence of
other phases besides hydroxyapatite, cristallinity and
chemical groups were also investigated. Size range was
determined by vibratory sieving using 75, 125, 250, 350, 420
and 600mm aperture screen size (ABNT). Scanning electron
microscopy (SEM - ZEISS, DSM 940A model) was used to
investigate granules morphology and granules porosity. The
specific surface area of each hydroxyapatite was determined
by BET analysis which estimates of surface area by nitrogen
adsorption at 77K7.
X-ray diffraction (XRD) allows the identification of other
crystalline phases besides hydroxyapatite and the unit cell
parameters. Cristallinity was determined by the methodology
used by Landi, et al.10, which results in the following formula:
Xc = 1- (V112/300 / I 300) x 100,
where Xc = the sample cristallinity in %, I300 is the intensity
of (300) reflection and V112/300 is the intensity of the hollow
between (112) and (300) reflections. XRD analysis was carried
out in a Rigaku MINIFLEX XRD operating at 30 kV, 15mA and
CuKa radiation. Data was obtained in the range of 5-1000 2q.
Fourier-transform infrared spectroscopy (FTIR, ABB
Bomem Inc., MB series, Quebec, Canada) equipped with
reflectance attachment was also used in order to confirm XRD
results and to detect some groups, such as  CO3
2-. The spectra
were collected at room temperature at a nominal resolution of
4.00 and number of sample scans equal to 1000. The FTIR
spectra were recorded in the 400 – 4000 cm-1 range using
specular reflection.
One gram of each granule was randomly separated and
crushed into a fine powder for XRD and FTIR analysis. All
procedures were conducted in duplicates and run in separated
experiments.
RESULTS
Table 1 shows the particle size obtained and the range
size indicated in the manufacturer’s specifications. Despite
some error associated with the methodology used, the only
sample that clearly is in accordance with these specifications
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was sample HA-6. Figure 1 shows SEM image (50x
magnification) and the BET specific surface area for each
condition. It is possible to observe that sample HA-3 exhibits
the smallest particle size, which corresponds to a high surface
area (49.6 m2/g) while  sample HA-6 exhibits large particles
(250 - > 600 mm) but also large pores. Thus, the highest specific
surface area of HA-6 (84.5 m2/g) is probably a consequence
of the porosity observed on these granules, which is
compatible with the bovine bone origin. Samples HA-3 and
HA-4 exhibited intermediate values of surface area, and, for
samples HA-1, HA-2 and HA-5, the BET specific surface areas
were relatively low.
Figure 2 shows the XRD pattern (displayed range in 20-
60°) of all samples. Only hydroxyapatite was identified (9-432
JCPDS card) with the three most intense peaks corresponding
to (211), (300) and (002) planes, respectively. The crystallinity
percentage was also indicated in Figure 2 and shows that
HA-1, HA-2 and HA-5 have highest, HA-3 intermediate and
HA-4 and HA-6 the lowest crystallinity.
Figure 3 shows the FTIR spectra of the samples examined.
The bands at 640 and 3575 cm-1 are characteristic OH-
absorption bands of HA. The band at 1650 cm-1 was assigned
to adsorbed H2O. The absorption bands at 1092, 1044, 1036,
960, 602, 573, and 475 cm-1 were assigned to the vibration in
the PO4
3- group of the hydroxyapatite (HA). The C-O vibration
in the CO3
2- group was located in the 1414-1545 cm-1 range
and at 875 cm-1, corresponding to A-type and B-type of
carbonated apatite, respectively, and were largely variable
from one sample to another. The triplet around 2000 cm-1 was
not identified. All granules examined show a composition
compatible with that of hydroxyapatite containing variable
CO3
2- substitution. The samples were assumed to have  high,
medium or low CO3
2- substitution, based on the comparison
of  the relative intensity of CO3
2- bands to the phosphate
band. For example, HA-1, HA-5 and HA-6 were classified as
high CO3
2- content, which may improve “in vivo” degradation.
HA-3 and HA-4 were considered as containing intermediate
CO3
2- content, while carbonate substitution was almost
absent on sample HA-2.
All granules that have exhibited non-expected results were
re-characterized in order to confirm previous results. In the
case of samples HA-1 and HA-5, new granules were bought
and all methodology was again applied. No discrepancies
were observed between samples from different batches.
SAMPLE Particle size (µm)
   Sieved    Manufacturer data
HA-1 < 75 - 600 250-450
HA-2 250 - > 600 500-1000
HA-3 <75 - 125 250-1000
HA-4 < 75  - 420 300-400
HA-5 < 75 - 600 250-450
HA-6 250 - > 600 250-1000
TABLE 1- Comparison between particle size determined
by sieving and the manufacturers’ specifications. HA-
samples in granular form
FIGURE 1-  Scanning electron micrography (50x magnification) and the BET specific surface area for each hydroxyapatite
examined
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DISCUSSION
Synthetic and natural calcium phosphate-based materials
may be a suitable alternative for the use of autogenous graft.
However, the use of these materials is sometimes avoided
due to lack of information or to contradiction between
manufacturers’ specifications (clinical indication) and clinical
results. The results showed that the hydroxyapatite examined
had variable physicochemical properties, which is in
disagreement with the manufacturers’ specifications. This
discrepancy may affect the materials’ performance.
Properties such as solubility and surface reactivity are
highly dependent on the calcium phosphate composition and
surface texture. Such characteristics will strongly affect the
nature of the biologically equivalent (carbonated) apatite
formed when calcium phosphates enter in contact with bone
tissue8. In fact, the low efficiency of  calcined hydroxyapatite
granules in producing bone-like apatite was attributed to the
slow dissolution capacity of this sample, probably related to
the small quantity of tricalcium phosphate (TCP) produced
during heat treatment14. With the aim of increasing
degradability in biological fluids, some authors use biphasic
(HA + TCP) instead of pure hydroxyapatite12.
Particle size and size range are very important, as they
directly affect the surface area available to react with cells
and biological fluid. Ducheyne and Qiu8 pointed out the
relevance of a straight distribution in order to allow an
adequate vascularization. If the distribution is large, the smaller
particles tend to obstruct the spaces among the larger particles,
thus reducing vascularization. Conversely, if the distribution
is kept narrow, HA resorbability will increase with reducing
particle size, i.e., with the increase in specific surface area.
This is the case of HA-3 when compared with HA-1. Both are
synthetic in origin, and the resorbability attributed by the
manufacturer of HA-3 may be a consequence of the higher
surface area value. Conz7 (2003) analyzed the particle size
distribution determined by laser light scattering (LLS),
showing that HA-1 and HA-5 exhibited the larger distribution,
when compared with the other examined hydroxyapatites.
HA-1 granules were in the range of 16-450mm and HA-5 in
the range of 0.5-204mm.
Another mean to increase resorbability by the increase in
the surface area is to produce porous granules. According to
several authors2,6,13,16,17, pore diameter should be higher than
100ìm for the continued bone ingrowth. Furthermore, the
quantity of new bone formed is directly proportional to pore
size4. Porous granules may be artificially made by convenient
processing of synthetic HA14 or may be consequence of the
use of cancellous medullar bovine bone.
Considering that all samples examined were composed
only of hydroxyapatite and the tendency of parameters surface
area, crystallinity, and carbonate substitution in affecting
biodegradability, these three parameters can be used to
estimate the degradation behavior to make a comparison with
manufacturers’ indications. Table 2 summarizes data obtained
for all hydroxyapatites studied. Samples HA-1 and HA-5
exhibited similar results, although they were produced by the
same company and described as non-resorbable and
resorbable, respectively. As they have low surface area (4.4
m2/g) coupled with high cristallinity (> 90%) they can be
assumed to be non-resorbable. However, the relatively high
carbonate content may attenuate this tendency. For all
samples – except HA-5 - the manufacturers’ specifications
were not contradicted by the qualitative estimation of
biodegradability. However, only sample HA-6 granule exactly
matches these specifications. In order to quantify the
FIGURE 2- XRD pattern (displayed range in 20-60°) of all
hydroxyapatite samples. No other phase than
hydroxyapatite was identified. Crystallinity varied from 30
to 92 %
FIGURE 3- FTIR spectra of samples examined.
a) HA-1 and HA-2
b) HA-3 and HA-4
c) HA-5 and HA-6
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Manufacturers’ specification Surface Cristallinity Carbonate Expected
Area % Biodegradability
HA-1(synthetic, non-resorbable) low high high moderate-low
HA-2(synthetic, non-resorbable) low high low low
HA-3 (synthetic, resorbable) moderate moderate moderate moderate
HA-4 (synthetic, resorbable) moderate low moderate moderate
HA-5 (natural HA, resorbable) low high high moderate-low
HA-6 (inorganic bovine bone, high low high fast
resorbable)
TABLE 2- Correlation between expected biodegradability and the manufacturers’ specifications
biodegradability of these materials, the ISO/FDIS 10993-
14:2001 degradation test should be used.
Although only six commercial hydroxyapatite granules
were analyzed in this paper, it is interesting to point out the
urgent need for the development of a Brazilian standard for
this kind of products. The reliability of medical and dental
profisionals may be increased if these standards were
approved and quality control was implemented.
CONCLUSIONS
The six granules examined were composed by basically
pure hydroxyapatite. Strong differences were observed in
terms of crystallinity, surface area and carbonate content and,
therefore, different “in vivo” behavior can be expected. For
all samples – except for HA-5 - the manufacturers’
specifications were not contradicted by the qualitative
estimation of biodegradability. However, only sample HA-6
exhibited characteristics in perfect agreement with these
specifications.
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